SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-071612
Filing Date
2020-03-12
Accepted
2020-03-12 16:24:08
Documents
5
Period of Report
2020-03-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d859106d8k.htm 8-K 17268
2 EX-99.1 d859106dex991.htm EX-99.1 78050
3 GRAPHIC g859106dsp04.jpg GRAPHIC 14266
4 GRAPHIC g859106g0312075001722.jpg GRAPHIC 16475
5 GRAPHIC g859106g0312075001971.jpg GRAPHIC 10399
  Complete submission text file 0001193125-20-071612.txt   153891
Mailing Address 900 S. CAPITAL OF TEXAS HIGHWAY SUITE 150 AUSTIN TX 78746
Business Address 900 S. CAPITAL OF TEXAS HIGHWAY SUITE 150 AUSTIN TX 78746 512-614-1848
Savara Inc (Filer) CIK: 0001160308 (see all company filings)

IRS No.: 841318182 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32157 | Film No.: 20709128
SIC: 2834 Pharmaceutical Preparations